Literature DB >> 9722371

Extracorporeal membrane oxygenation: potential for adults and children?

G J Peek1, H M Killer, A W Sosnowski, R K Firmin.   

Abstract

Extracorporeal membrane oxygenation is a proven therapy for severe neonatal respiratory failure. Extracorporeal membrane oxygenation for older children and adults who are failing to respond to maximal conventional therapy is more controversial, but survival figures of 50-80% can be obtained, in patients with an expected survival of 0-20% with conventional treatment.

Entities:  

Mesh：

Year:  1998        PMID： 9722371

Source DB:  PubMed          Journal:  Hosp Med        ISSN： 1462-3935


  4 in total

1.  Early stabilization of traumatic aortic transection and mitral valve regurgitation with extracorporeal membrane oxygenation.

Authors:  David L Lambrechts; Francis Wellens; Rik A Vercoutere; Raf De Geest
Journal:  Tex Heart Inst J       Date:  2003

2.  Effectiveness of Vancomycin Dosing Guided by Therapeutic Drug Monitoring in Adult Patients Receiving Extracorporeal Membrane Oxygenation.

Authors:  Prashanti Marella; Jason Roberts; Karen Hay; Kiran Shekar
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation.

Authors:  Hussain Mulla; Suneel Pooboni
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

4.  Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

Authors:  Hussain Mulla; Fazal Nabi; Sanjiv Nichani; Graham Lawson; R K Firmin; David R Upton
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.